Profound Medical Corp Stock Toronto S.E.
Stocks
PRN
CA74319B1067
Advanced Medical Equipment & Technology
|
End-of-day quote
Toronto S.E.
|
||
| - CAD | - |
|
| 09-01 | Profound Medical Appoints Richard Fabian as President | MT |
| 09-01 | Profound Medical Appoints Richard Fabian President | MT |
| Market Cap | 306M 221M 190M 180M 163M 21.08B 308M 2.14B 822M 10.73B 829M 811M 33.89B | P/E 2026 * |
-6.99x | P/E 2027 * | -10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 306M 221M 190M 180M 163M 21.08B 308M 2.14B 822M 10.73B 829M 811M 33.89B | EV / Sales 2026 * |
8.45x | EV / Sales 2027 * | 5.15x |
| Free-Float |
95.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Profound Medical Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 71 | 2016-08-14 |
Richard Fabian
PSD | President | 59 | 2026-08-31 |
Matthew Sobczyk
DFI | Director of Finance/CFO | - | 2026-08-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Arun Menawat
CHM | Chairman | 71 | - |
Brian Ellacott
BRD | Director/Board Member | 68 | 2018-06-13 |
Arthur Rosenthal
BRD | Director/Board Member | 79 | 2018-06-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.10% | -0.65% | +27.19% | +19.36% | 225B | |
| -0.19% | -3.62% | +5.31% | -20.72% | 141B | |
| +2.41% | +0.67% | -17.91% | +21.95% | 130B | |
| -0.28% | -10.08% | -58.15% | -19.21% | 62.29B | |
| +2.28% | +1.29% | -18.18% | -13.64% | 49.39B | |
| -2.77% | -6.15% | +8.77% | +15.31% | 48.63B | |
| +2.66% | -2.61% | +19.22% | +29.53% | 41.42B | |
| +1.67% | -0.25% | +38.24% | +52.80% | 40.12B | |
| -0.60% | -4.41% | -19.20% | +49.15% | 31.23B | |
| Average | +0.73% | -3.23% | -1.64% | +14.95% | 85.52B | |
| Weighted average by Cap. | +0.75% | -2.40% | +2.83% | +10.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36.22M 26.11M 22.49M 21.3M 19.3M 2.49B 36.4M 253M 97.27M 1.27B 98.04M 95.89M 4.01B | 59.46M 42.86M 36.93M 34.96M 31.69M 4.09B 59.76M 415M 160M 2.08B 161M 157M 6.58B |
| Net income | -44.08M -31.77M -27.38M -25.92M -23.49M -3.04B -44.3M -308M -118M -1.54B -119M -117M -4.88B | -31.27M -22.54M -19.42M -18.39M -16.67M -2.15B -31.42M -218M -83.97M -1.1B -84.64M -82.78M -3.46B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PRN Stock
- PRN Stock
Select your edition
All financial news and data tailored to specific country editions
